Efficacy and Safety of Prurisol Administered Orally for Active Moderate to Severe Chronic Plaque Psoriasis
Clinical trial NCT02949388 · COMPLETED
Trial details
- NCT number
- NCT02949388
- Sponsor
- Innovation Pharmaceuticals, Inc.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2016-11-01
- Primary completion
- 2017-11-01
- Enrollment
- 199
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.